Checkpoint Inhibition: Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors in Hodgkin Lymphoma.
Cancer J. 2016 Jan 1; 22 (1): 17-22.
Release the hounds! Activating the T-cell response to cancer.
N. Engl. J. Med.. 2015 Jan 22;372(4):374-5.
Tumor immunotherapy directed at PD-1.
N. Engl. J. Med. 2012 Jun 28;366(26):2517-9.